Genenta Science S.p.A. (GNTA): Capital Expenditures

Annual figures by period end, from SEC filings.

7.6K EUR
Year ended 2025-12-31
-34.4%
3-year compound annual growth
-18.2%
5-year compound annual growth
27.1K EUR2020-12-31: 20.9K EUR2021-12-31: 9.0K EUR2022-12-31: 27.1K EUR2023-12-31: 13.8K EUR2024-12-31: 4.5K EUR2025-12-31: 7.6K EUR7.6K EUR
2020-12-31 Capital Expenditures (EUR) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-317.6K EUR+70.7%2026-04-01, From 2025-01-01
2024-12-314.5K EUR-67.6%2026-04-01, From 2024-01-01
2023-12-3113.8K EUR-49.1%2026-04-01, From 2023-01-01
2022-12-3127.1K EUR+200.5%2025-03-28, From 2022-01-01
2021-12-319.0K EUR-56.8%2024-03-29, From 2021-01-01
2020-12-3120.9K EURn/a2023-04-21, From 2020-01-01